{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:51:40Z","timestamp":1791525100766,"version":"4.3.4"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Antimicrobial resistance (AMR) is a critical global challenge, with an estimated \u226510 million deaths per year by 2050.\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      (\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      ), a critical priority bacterial pathogen, is rapidly developing resistance even against next-generation (meropenem) and last-resort (colistin) antibiotics, whereas the pipeline for discovery and development of new antibiotic(s) for treatment of antibiotic-resistant\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      infections is a lengthy, resource-intensive, and costly process and hence demands exploring alternative and effective treatment strategies. Capitalizing on the simultaneous emergence of collateral sensitivity (CS) to resistant antibiotics can therefore be a rapid and effective strategy to fill the gap.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Adaptive laboratory evolution was enforced in\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      (American Type Culture Collection [ATCC] and clinical strains) by exposing it to sequentially increasing sub-lethal dosages (0.25, 0.5, and 1xMIC) of colistin and meropenem, and a panel of pathogens representing early (0.25xMIC), mid (0.5xMIC), and late (1xMIC) stages of emergence of AMR was developed. Similarly, colistin (1xMIC)-resistant\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      cells were also adapted to develop resistance against meropenem. Matrix-Assisted Laser Desorption\/Ionization Time-of-Flight (MALDI-TOF) for pathogen identification and VITEK-2 for antibiotic susceptibility testing (AST) profiles validated resistant pathogens, which were then proteomic profiled to investigate CS between colistin and meropenem at both phenotypic and proteome levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      AST of developed panels revealed that colistin-resistant pathogens became sensitive to meropenem during adaptation to colistin, representing CS, which was validated by the emergence of colistin sensitivity when colistin-resistant\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      adapted against meropenem. Proteomic analysis of the resistant panels identified a total of 3,126 proteins, including 23 and 5 differentially expressed proteins (DEPs) in colistin- and meropenem-resistant pathogens, respectively. Among these, 12 proteins (\n                      <jats:italic>phoP<\/jats:italic>\n                      ,\n                      <jats:italic>arnB\/arnD\/arnT<\/jats:italic>\n                      , and\n                      <jats:italic>pmrD\/pmrA<\/jats:italic>\n                      ) (associated with two components: system regulator and antibiotic resistance);\n                      <jats:italic>degP<\/jats:italic>\n                      ,\n                      <jats:italic>kdpB<\/jats:italic>\n                      ,\n                      <jats:italic>maeA<\/jats:italic>\n                      , f\n                      <jats:italic>rmR<\/jats:italic>\n                      ,\n                      <jats:italic>fhuC<\/jats:italic>\n                      , and\n                      <jats:italic>entF<\/jats:italic>\n                      (responsible for virulence and stress adaptation); and\n                      <jats:italic>fhuC<\/jats:italic>\n                      ,\n                      <jats:italic>entF<\/jats:italic>\n                      , and\n                      <jats:italic>amn<\/jats:italic>\n                      (required for iron acquisition and persistence) showed altered pattern matching along with CS, that is, upregulated during emergence of colistin resistance along with meropenem sensitivity and conversely downregulated during emergence of colistin sensitivity along with meropenem-resistance in colistin-1x resistant\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study, for the first time, developed a unique panel of colistin- and meropenem-resistant\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      cells representing the early, mid, and late stages of AMR emergence. The simultaneous emergence of CS for meropenem while developing resistance against colistin among the panels may pave the way to devise antibiotic cycling and\/or co-dosing approaches, and modulation of the expression of the identified 12 potential proteomic biomarkers may be utilized to regulate the emergence of CS for meropenem in colistin-resistant pathogens for combating colistin-resistant infections.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2026.1960299","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:30:07Z","timestamp":1791523807000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Adaptive laboratory evolution and proteomic insight on collateral sensitivity for meropenem in colistin-resistant Klebsiella pneumoniae"],"prefix":"10.3389","volume":"17","author":[{"given":"Sevaram","family":"Singh","sequence":"first","affiliation":[{"name":"BRIC-Translational Health Science and Technology Institute, NCR Biotech Science Cluster, 3rd Milestone, Faridabad\u2013Gurugram Expressway","place":["Faridabad, India"]},{"name":"Jawaharlal Nehru University","place":["New Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovnish","family":"Thakur","sequence":"additional","affiliation":[{"name":"BRIC-Translational Health Science and Technology Institute, NCR Biotech Science Cluster, 3rd Milestone, Faridabad\u2013Gurugram Expressway","place":["Faridabad, India"]},{"name":"Jawaharlal Nehru University","place":["New Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sapna","sequence":"additional","affiliation":[{"name":"BRIC-Translational Health Science and Technology Institute, NCR Biotech Science Cluster, 3rd Milestone, Faridabad\u2013Gurugram Expressway","place":["Faridabad, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"BRIC-Translational Health Science and Technology Institute, NCR Biotech Science Cluster, 3rd Milestone, Faridabad\u2013Gurugram Expressway","place":["Faridabad, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[{"name":"BRIC-Translational Health Science and Technology Institute, NCR Biotech Science Cluster, 3rd Milestone, Faridabad\u2013Gurugram Expressway","place":["Faridabad, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Maitry","sequence":"additional","affiliation":[{"name":"BRIC-Translational Health Science and Technology Institute, NCR Biotech Science Cluster, 3rd Milestone, Faridabad\u2013Gurugram Expressway","place":["Faridabad, India"]},{"name":"Jawaharlal Nehru University","place":["New Delhi, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra","family":"Mani","sequence":"additional","affiliation":[{"name":"BRIC-Translational Health Science and Technology Institute, NCR Biotech Science Cluster, 3rd Milestone, Faridabad\u2013Gurugram Expressway","place":["Faridabad, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj","family":"Kumar","sequence":"additional","affiliation":[{"name":"BRIC-Translational Health Science and Technology Institute, NCR Biotech Science Cluster, 3rd Milestone, Faridabad\u2013Gurugram Expressway","place":["Faridabad, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"ref1","first-page":"1845444","article-title":"Phenotypic, PCR, and whole-genome sequencing characterization of carbapenem-resistant Acinetobacter baumannii in Makkah and Riyadh, Saudi Arabia: AST discordance and local genomic micro-clusters","volume-title":"Frontiers in Microbiology, Antimicrobials, Resistance and Chemotherapy","author":"Alquait","year":"2026"},{"key":"ref2","first-page":"533","article-title":"Distinct evolution of colistin resistance associated with experimental resistance evolution models in Klebsiella pneumoniae","volume-title":"J. Antimicrob. Chemother","author":"Aulin","year":"2021"},{"key":"ref3","first-page":"e2416426121","article-title":"OmpA controls order in the outer membrane and shares the mechanical load","volume-title":"Proc. Natl. Acad. Sci","author":"Benn","year":"2024"},{"key":"ref4","first-page":"280","article-title":"Molecular mechanisms of antibiotic resistance revisited","volume-title":"Nat. Rev. Microbiol","author":"Darby","year":"2023"},{"key":"ref5","first-page":"9078","article-title":"Antimicrobial resistance, equity and justice in low-and middle-income countries: an intersectional critical interpretive synthesis","volume-title":"Nat. Commun","author":"Davis","year":"2025"},{"key":"ref6","first-page":"1691215","article-title":"Combating Klebsiella pneumoniae: from antimicrobial resistance mechanisms to phage-based combination therapies","volume-title":"Frontiers in Cellular and Infection Microbiology, Virus and Host","author":"Ding","year":"2025"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/9781119814085.ch7","article-title":"Diversity, transmission and selective pressure on the proteome of Pseudomonas aeruginosa","volume-title":"Microbiological Identification using MALDI\u2010TOF and Tandem Mass Spectrometry: Industrial and Environmental Applications","author":"Duncan","year":"2023"},{"key":"ref8","first-page":"1698809","article-title":"Antimicrobial resistance at a turning point: microbial drivers, one health, and global futures","volume-title":"Front. Microbiol","author":"Elbehiry","year":"2025"},{"key":"ref9","first-page":"50","article-title":"Current economic and regulatory challenges in developing antibiotics for gram-negative bacteria","volume-title":"npj Antimicrob. Resist","author":"Gargate","year":"2025"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00052-1","article-title":"Assessment of the reversibility of resistance in the absence of antibiotics and its relationship with the resistance gene's fitness cost: a genetic study with mcr-1","volume-title":"The Lancet Microbe","author":"Guo","year":"2024"},{"key":"ref11","first-page":"1723","article-title":"Tackling antibiotic resistance by inducing transient and robust collateral sensitivity","volume-title":"Nat. Commun","author":"Hernando-Amado","year":"2023"},{"key":"ref12","first-page":"e1011233","article-title":"Klebsiella pneumoniae causes bacteremia using factors that mediate tissue-specific fitness and resistance to oxidative stress","volume-title":"PLOS Pathogens","author":"Holmes","year":"2023"},{"key":"ref13","first-page":"204ra132","article-title":"Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development","volume-title":"Science Translational Medicine","author":"Imamovic","year":"2013"},{"key":"ref14","first-page":"1816741","article-title":"Antibiotic resistance in K. pneumoniae: perspectives, challenges, health risks, therapeutic approaches","volume-title":"Front. Microbiol","author":"Kandemir","year":"2026"},{"key":"ref15","first-page":"8939","article-title":"Identification of metabolite extraction method for targeted exploration of antimicrobial resistance associated metabolites of Klebsiella pneumoniae","author":"Kumar","year":"2022"},{"key":"ref16","first-page":"4352","article-title":"Genome-wide analysis captures the determinants of the antibiotic cross-resistance interaction network","volume-title":"Nat. Commun","author":"L\u00e1z\u00e1r","year":"2014"},{"key":"ref17","first-page":"1888","article-title":"Collateral sensitivity to pleuromutilins in vancomycin-resistant Enterococcus faecium","volume-title":"Nat. Commun","author":"Li","year":"2022"},{"key":"ref18","first-page":"732","article-title":"Risk factors for bloodstream infections and mortality in carbapenem-resistant versus susceptible Klebsiella pneumoniae: a six-year retrospective cohort study","volume-title":"Nat. Commun","author":"Li","year":"2026"},{"key":"ref19","first-page":"673503","article-title":"Molecular mechanisms of colistin resistance in Klebsiella pneumoniae in a tertiary care teaching hospital","volume-title":"Frontiers in Cellular and Infection Microbiology, Parasite and Host","author":"Liu","year":"2021"},{"key":"ref20","first-page":"1976","article-title":"Collateral sensitivity profiling in drug-resistant Escherichia coli identifies natural products suppressing cephalosporin resistance","volume-title":"Nat. Commun","author":"Liu","year":"2023"},{"key":"ref21","first-page":"3718","article-title":"Analysis of the networks controlling the antimicrobial-peptide-dependent induction of Klebsiella pneumoniae virulence factors","volume-title":"ASM Journals, Infection and Immunity","author":"Llobet","year":"2011"},{"key":"ref22","first-page":"100961","article-title":"Collateral sensitivity between tetracyclines and aminoglycosides constrains resistance evolution in carbapenem-resistant Klebsiella pneumoniae","volume-title":"Drug Resistance Updates","author":"Ma","year":"2023"},{"key":"ref23","first-page":"e3003852","article-title":"Resistance potentiators: evolutionary catalysts of antibiotic resistance","volume-title":"PLOS Biology","author":"MacLean","year":"2026"},{"key":"ref24","first-page":"lxaf241","article-title":"Sublethal exposure to benzalkonium chloride induced biocide-antibiotic cross-resistance in hypervirulent L. monocytogenes","volume-title":"Journal of Applied Microbiology","author":"Macleod","year":"2025"},{"key":"ref25","first-page":"1449","article-title":"Duplicated antibiotic resistance genes reveal ongoing selection and horizontal gene transfer in bacteria","volume-title":"Nat. Commun","author":"Maddamsetti","year":"2024"},{"key":"ref26","first-page":"5965","article-title":"Structural bases of peptidoglycan recognition by lysostaphin SH3b domain","volume-title":"Scientific Reports","author":"Mitkowski","year":"2019"},{"key":"ref27","first-page":"1199","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume-title":"The Lancet","author":"Naghavi","year":"2024"},{"key":"ref28","first-page":"1007","article-title":"Mechanisms of antimicrobial resistance: from genetic evolution to clinical manifestations","volume-title":"AIMS Microbiology","author":"Nusrat","year":"2025"},{"key":"ref29","first-page":"e00111-25","article-title":"Proteomic study of evolved Pseudomonas aeruginosa strains grown in Staphylococcus aureus-and Klebsiella pneumoniae-conditioned media","volume-title":"ASM Journals, mSystems","author":"Pan","year":"2025"},{"key":"ref30","first-page":"e01972","article-title":"Clinical performance of the VITEK REVEAL fast antimicrobial susceptibility test within a real-world workflow for gram-negative bacteremia: comparison with QMAC-dRAST and conventional methods","volume-title":"Microbiology Spectrum","author":"Park","year":"2026"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012874","article-title":"Interventions to address antimicrobial resistance: an ethical analysis of key tensions and how they apply in low-income and middle-income countries","volume-title":"BMJ Global Health","author":"Pokharel","year":"2024"},{"key":"ref32","first-page":"107028","article-title":"Comparative genome analysis reveals putative and novel antimicrobial resistance genes common to the nosocomial infection pathogens","volume-title":"Microbial Pathogenesis","author":"Sahayarayan","year":"2024"},{"key":"ref33","first-page":"671","article-title":"Translating eco-evolutionary biology into therapy to tackle antibiotic resistance","volume-title":"Nat. Rev. Microbiol","author":"Sanz-Garc\u00eda","year":"2023"},{"key":"ref34","first-page":"1","article-title":"The demise of the antibiotic pipeline: the Bayer case","volume-title":"Humanities and Social Sciences Communications","author":"Skender","year":"2024"},{"key":"ref35","year":"2026"},{"key":"ref36","first-page":"536","article-title":"Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance","author":"Wright","year":"2015"},{"key":"ref37","first-page":"1741170","article-title":"Clinical and molecular characteristics, antibiotic susceptibility, risk factors and predictors of mortality in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in southern Sichuan, China: a 5-year multicenter study","volume-title":"Front. Cell. Infect. Microbiol","author":"Xie","year":"2026"},{"key":"ref38","first-page":"73","article-title":"Increasing polymyxin resistance in clinical carbapenem-resistant Klebsiella pneumoniae strains in China between 2000 and 2023","volume-title":"Commun. Med","author":"Xie","year":"2025"},{"key":"ref39","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02327-14","article-title":"Insights into substrate specificity of NlpC\/P60 cell wall hydrolases containing bacterial SH3 domains","author":"Xu","year":"2015"},{"key":"ref40","first-page":"2614739","article-title":"Can we escape from top-priority ESKAPE pathogens?","volume-title":"Emerg. Microbes Infect","author":"Zeng","year":"2026"},{"key":"ref41","first-page":"e01728-24","article-title":"RamA upregulates the ATP-binding cassette transporter mlaFEDCB to mediate resistance to tetracycline-class antibiotics and the stability of membranes in Klebsiella pneumoniae","volume-title":"Microbiol. Spectr","author":"Zhao","year":"2025"},{"key":"ref42","first-page":"dlab175","article-title":"Identification of antibiotic collateral sensitivity and resistance interactions in population surveillance data","volume-title":"JAC-Antimicrobial Resistance","author":"Zwep","year":"2021"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1960299\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:30:15Z","timestamp":1791523815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1960299\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":42,"alternative-id":["10.3389\/fmicb.2026.1960299"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1960299","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"article-number":"1960299"}}